Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Anesthesiology. 2012 May;116(5):1013–1024. doi: 10.1097/ALN.0b013e31825153ea

Figure 5. Gabapentin reduces the number of secretory vesicle fusion events but not the quantal size or kinetics of catecholamine release from each vesicle.

Figure 5

Carbon fiber amperometry was used to quantify the number, quantal size, and kinetics of individual vesicular fusion events. (A) A representative amperometry recording from a control cell stimulated with 30 mM KCl. Each upward deflection (spike) on the current trace is produced by oxidation of the catecholamines released from a single vesicular fusion event. The inset shows a cartoon representation of the recoding configuration (above) and an expanded view of a few spikes is shown below. (B) The number of amperometric spikes was determined for each cell over a 2-min period. The box graph shows the 25th percentile, median, and 75th percentile distribution of vesicular fusion rate (spikes per minute) for control cells (n = 26 ) and cells treated for 18–24 hours with 1mM gabapentin (n = 25). The whiskers represent the smallest and largest non-outliers in each population of cells. Gabapentin produced a statistically significantly reduction in the rate of fusion events compared to matched controls (* p = 0.046, Mann-Whitney test). (C–F) Other parameters of the amperometric spikes (amplitude, charge, slope, and duration) were analyzed and a median value for each cell calculated. Pooled values (mean ± SEM) for each parameter are shown and were compared. No statistically significant differences were found between gabapentin treated cells (GBP) and control cells (ctl).